Header Logo

Connection

PEDRO PIEDRA to Humans

Back to Details
This is a "connection" page, showing publications PEDRO PIEDRA has written about Humans.
PEDRO PIEDRA
Connection Strength
1.344
Humans
  1. Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. PLoS One. 2025; 20(1):e0317033.
    View in: PubMed
    Score: 0.025
  2. Respiratory viral detection in the plasma and cerebrospinal fluid (CSF) of young febrile infants. Influenza Other Respir Viruses. 2024 02; 18(2):e13250.
    View in: PubMed
    Score: 0.023
  3. The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent. J Virol. 2023 05 31; 97(5):e0025423.
    View in: PubMed
    Score: 0.022
  4. Adult Memory T Cell Responses to the Respiratory Syncytial Virus Fusion Protein During a Single RSV Season (2018-2019). Front Immunol. 2022; 13:823652.
    View in: PubMed
    Score: 0.020
  5. Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein. Vaccine. 2022 01 24; 40(3):536-543.
    View in: PubMed
    Score: 0.020
  6. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2. Front Immunol. 2021; 12:693462.
    View in: PubMed
    Score: 0.020
  7. SARS-CoV-2 re-infection versus prolonged shedding: A case series. Influenza Other Respir Viruses. 2021 11; 15(6):691-696.
    View in: PubMed
    Score: 0.019
  8. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Viruses. 2021 05 26; 13(6).
    View in: PubMed
    Score: 0.019
  9. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader. J Infect Dis. 2021 05 20; 223(9):1528-1537.
    View in: PubMed
    Score: 0.019
  10. Profile of respiratory syncytial virus prefusogenic fusion protein nanoparticle vaccine. Expert Rev Vaccines. 2021 04; 20(4):351-364.
    View in: PubMed
    Score: 0.019
  11. Understanding the Impact of Resistance to Influenza Antivirals. Clin Microbiol Rev. 2021 03 17; 34(2).
    View in: PubMed
    Score: 0.019
  12. A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas. Vaccine. 2021 02 22; 39(8):1248-1256.
    View in: PubMed
    Score: 0.019
  13. Premature Infants With Respiratory Syncytial Virus (RSV): The Need for Both Maternal and Pediatric RSV Prevention Strategies. J Infect Dis. 2020 09 01; 222(7):1070-1072.
    View in: PubMed
    Score: 0.018
  14. Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2). Pediatr Infect Dis J. 2020 08; 39(8):700-705.
    View in: PubMed
    Score: 0.018
  15. Long-Term Healthcare Costs Associated With Respiratory Syncytial Virus Infection in Children: The Domino Effect. J Infect Dis. 2020 03 28; 221(8):1205-1207.
    View in: PubMed
    Score: 0.018
  16. The Risk of Serious Bacterial Infection in Febrile Infants 0-90 Days of Life With a Respiratory Viral Infection. Pediatr Infect Dis J. 2019 04; 38(4):355-361.
    View in: PubMed
    Score: 0.017
  17. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults. Front Immunol. 2019; 10:706.
    View in: PubMed
    Score: 0.017
  18. RSV Strains and Disease Severity. J Infect Dis. 2019 01 29; 219(4):514-516.
    View in: PubMed
    Score: 0.016
  19. Live Attenuated Influenza Vaccine: Will the Phoenix Rise Again? Pediatrics. 2019 02; 143(2).
    View in: PubMed
    Score: 0.016
  20. A Cross-sectional Surveillance Study of the Frequency and Etiology of Acute Respiratory Illness Among Pregnant Women. J Infect Dis. 2018 07 13; 218(4):528-535.
    View in: PubMed
    Score: 0.016
  21. Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients. J Infect Dis. 2018 03 28; 217(8):1247-1256.
    View in: PubMed
    Score: 0.015
  22. Local Versus Global Enterovirus (EV) Surveillance: A Discussion for the Need for Active Surveillance to Guide EV-A71 Vaccines. J Infect Dis. 2017 12 12; 216(11):1337-1339.
    View in: PubMed
    Score: 0.015
  23. Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B. PLoS One. 2017; 12(4):e0175792.
    View in: PubMed
    Score: 0.015
  24. Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis. J Infect Dis. 2016 08 15; 214(4):649-55.
    View in: PubMed
    Score: 0.014
  25. Respiratory Syncytial Virus (RSV): Neutralizing Antibody, a Correlate of Immune Protection. Methods Mol Biol. 2016; 1442:77-91.
    View in: PubMed
    Score: 0.013
  26. A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. J Infect Dis. 2016 Feb 01; 213(3):411-22.
    View in: PubMed
    Score: 0.013
  27. Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season. Pediatr Infect Dis J. 2015 Jun; 34(6):566-70.
    View in: PubMed
    Score: 0.013
  28. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013. J Infect Dis. 2015 Feb 15; 211(4):582-9.
    View in: PubMed
    Score: 0.012
  29. Lactate dehydrogenase and caspase activity in nasopharyngeal secretions are predictors of bronchiolitis severity. Influenza Other Respir Viruses. 2014 Nov; 8(6):617-25.
    View in: PubMed
    Score: 0.012
  30. The significance of transplacental antibody against respiratory syncytial virus. J Infect Dis. 2014 Nov 15; 210(10):1526-8.
    View in: PubMed
    Score: 0.012
  31. Influenza A(H5N1) vaccines: are we better prepared for the next pandemic? J Infect Dis. 2014 Jan 01; 209(1):1-3.
    View in: PubMed
    Score: 0.011
  32. Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine. 2013 Jan 07; 31(3):524-32.
    View in: PubMed
    Score: 0.011
  33. Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics. 2012 Sep; 130(3):e492-500.
    View in: PubMed
    Score: 0.010
  34. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012 Aug; 166(8):700-6.
    View in: PubMed
    Score: 0.010
  35. Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus. Clin Infect Dis. 2012 Apr; 54(7):905-12.
    View in: PubMed
    Score: 0.010
  36. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis. 2010 Dec 01; 202(11):1626-33.
    View in: PubMed
    Score: 0.009
  37. Outpatient RSV lower respiratory infections among high-risk infants and other pediatric populations. Pediatr Pulmonol. 2010 Jun; 45(6):578-84.
    View in: PubMed
    Score: 0.009
  38. LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics. 2010 Feb; 125(2):e225-33.
    View in: PubMed
    Score: 0.009
  39. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Pediatrics. 2009 Jul; 124(1):170-8.
    View in: PubMed
    Score: 0.008
  40. Societal and economic consequences of influenza. Manag Care. 2008 Oct; 17(10 Suppl 10):8-14.
    View in: PubMed
    Score: 0.008
  41. The search for adenovirus 14 in children in Houston, Texas. Pediatr Infect Dis J. 2008 Jul; 27(7):653-4.
    View in: PubMed
    Score: 0.008
  42. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics. 2007 Sep; 120(3):e553-64.
    View in: PubMed
    Score: 0.007
  43. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007 May 15; 195(10):1532-40.
    View in: PubMed
    Score: 0.007
  44. Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatr Pulmonol. 2007 Jan; 42(1):66-74.
    View in: PubMed
    Score: 0.007
  45. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics. 2005 Sep; 116(3):e397-407.
    View in: PubMed
    Score: 0.006
  46. Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeys. Nat Commun. 2025 Jul 11; 16(1):6437.
    View in: PubMed
    Score: 0.006
  47. Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment. Sci Rep. 2025 Jul 01; 15(1):20526.
    View in: PubMed
    Score: 0.006
  48. Epidemiology and genotypic diversity of rhinovirus in school-age children with acute respiratory illnesses seeking medical care. J Clin Virol. 2025 Aug; 179:105806.
    View in: PubMed
    Score: 0.006
  49. Adenovirus in the neonatal intensive care unit: formidable, forgotten foe. J Pediatr. 2005 Apr; 146(4):447-8.
    View in: PubMed
    Score: 0.006
  50. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine. 2005 Feb 18; 23(13):1540-8.
    View in: PubMed
    Score: 0.006
  51. Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024. JAMA Pediatr. 2025 Feb 01; 179(2):179-187.
    View in: PubMed
    Score: 0.006
  52. Immunization against viral respiratory disease: a review. Pediatr Infect Dis J. 2004 Nov; 23(11 Suppl):S254-61.
    View in: PubMed
    Score: 0.006
  53. Infant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection. J Infect. 2024 Dec; 89(6):106305.
    View in: PubMed
    Score: 0.006
  54. Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten Cities. N Engl J Med. 2024 09 26; 391(12):1157-1159.
    View in: PubMed
    Score: 0.006
  55. Influenza C virus in U.S. children with acute respiratory infection 2016-2019. J Clin Virol. 2024 10; 174:105720.
    View in: PubMed
    Score: 0.006
  56. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. Antiviral Res. 2004 Jul; 63(1):51-9.
    View in: PubMed
    Score: 0.006
  57. Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020. Clin Infect Dis. 2024 05 15; 78(5):1352-1359.
    View in: PubMed
    Score: 0.006
  58. Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence. Nat Microbiol. 2024 May; 9(5):1382-1392.
    View in: PubMed
    Score: 0.006
  59. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Mar 07; 73(9):209-214.
    View in: PubMed
    Score: 0.006
  60. Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease. ACS Infect Dis. 2024 02 09; 10(2):715-731.
    View in: PubMed
    Score: 0.006
  61. Wastewater sequencing reveals community and variant dynamics of the collective human virome. Nat Commun. 2023 10 28; 14(1):6878.
    View in: PubMed
    Score: 0.006
  62. Genome type analysis of adenovirus types 3 and 7 isolated during successive outbreaks of lower respiratory tract infections in children. J Clin Microbiol. 2003 Oct; 41(10):4594-9.
    View in: PubMed
    Score: 0.006
  63. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 2003 Sep; 60(1):51-9.
    View in: PubMed
    Score: 0.006
  64. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine. 2003 Jul 28; 21(24):3479-82.
    View in: PubMed
    Score: 0.006
  65. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60.
    View in: PubMed
    Score: 0.006
  66. Wastewater pandemic preparedness: Toward an end-to-end pathogen monitoring program. Front Public Health. 2023; 11:1137881.
    View in: PubMed
    Score: 0.005
  67. Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020. Clin Infect Dis. 2023 02 08; 76(3):e1031-e1039.
    View in: PubMed
    Score: 0.005
  68. Clinical experience with respiratory syncytial virus vaccines. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S94-9.
    View in: PubMed
    Score: 0.005
  69. Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan. BMC Pediatr. 2023 01 21; 23(1):35.
    View in: PubMed
    Score: 0.005
  70. Diversity and evolution of computationally predicted T cell epitopes against human respiratory syncytial virus. PLoS Comput Biol. 2023 01; 19(1):e1010360.
    View in: PubMed
    Score: 0.005
  71. Clinical Presentation and Severity of Adenovirus Detection Alone vs Adenovirus Co-detection With Other Respiratory Viruses in US Children With Acute Respiratory Illness from 2016 to 2018. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):430-439.
    View in: PubMed
    Score: 0.005
  72. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children. Pediatrics. 2002 Oct; 110(4):662-72.
    View in: PubMed
    Score: 0.005
  73. Comparative analysis of three multiplex platforms for the detection of respiratory viral pathogens. J Clin Virol. 2022 11; 156:105274.
    View in: PubMed
    Score: 0.005
  74. Integrated relationship of nasopharyngeal airway host response and microbiome associates with bronchiolitis severity. Nat Commun. 2022 08 30; 13(1):4970.
    View in: PubMed
    Score: 0.005
  75. Future directions in vaccine prevention of respiratory syncytial virus. Pediatr Infect Dis J. 2002 May; 21(5):482-7.
    View in: PubMed
    Score: 0.005
  76. Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children. Semin Pediatr Infect Dis. 2002 Apr; 13(2):90-6.
    View in: PubMed
    Score: 0.005
  77. Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection. J Virol. 2022 04 13; 96(7):e0190421.
    View in: PubMed
    Score: 0.005
  78. Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment. Clin Infect Dis. 2022 02 11; 74(3):532-540.
    View in: PubMed
    Score: 0.005
  79. Respiratory Viral Infections and Infection Prevention Practices Among Women With Acute Respiratory Illness During Delivery Hospitalizations During the 2019-2020 Influenza Season. J Infect Dis. 2022 01 05; 225(1):50-54.
    View in: PubMed
    Score: 0.005
  80. Novel and extendable genotyping system for human respiratory syncytial virus based on whole-genome sequence analysis. Influenza Other Respir Viruses. 2022 05; 16(3):492-500.
    View in: PubMed
    Score: 0.005
  81. Population-Based Estimates of SARS-CoV-2 Seroprevalence in Houston, Texas as of September 2020. J Infect Dis. 2021 11 22; 224(10):1649-1657.
    View in: PubMed
    Score: 0.005
  82. Severe bronchiolitis profiles and risk of asthma development in Finnish children. J Allergy Clin Immunol. 2022 04; 149(4):1281-1285.e1.
    View in: PubMed
    Score: 0.005
  83. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections. BMC Med. 2021 10 01; 19(1):255.
    View in: PubMed
    Score: 0.005
  84. Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site. J Pediatric Infect Dis Soc. 2021 Sep 23; 10(8):872-879.
    View in: PubMed
    Score: 0.005
  85. Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals. PLoS One. 2021; 16(8):e0244468.
    View in: PubMed
    Score: 0.005
  86. Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma. Nat Commun. 2021 06 14; 12(1):3601.
    View in: PubMed
    Score: 0.005
  87. Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection. Vaccine. 2021 07 05; 39(30):4063-4071.
    View in: PubMed
    Score: 0.005
  88. Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerg Infect Dis. 2021 06; 27(6):1-9.
    View in: PubMed
    Score: 0.005
  89. Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology. Water Res. 2021 Jun 01; 197:117043.
    View in: PubMed
    Score: 0.005
  90. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 02 22; 13(1):e0351121.
    View in: PubMed
    Score: 0.005
  91. Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing. J Infect Dis. 2021 02 03; 223(2):268-277.
    View in: PubMed
    Score: 0.005
  92. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. J Infect Dis. 2001 Mar 01; 183(5):687-96.
    View in: PubMed
    Score: 0.005
  93. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. Vaccine. 2020 11 25; 38(50):7892-7896.
    View in: PubMed
    Score: 0.005
  94. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med. 2021 01; 9(1):21-32.
    View in: PubMed
    Score: 0.005
  95. Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'. Ann Rheum Dis. 2022 12; 81(12):e239.
    View in: PubMed
    Score: 0.005
  96. Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study. Pediatr Res. 2021 05; 89(7):1594-1597.
    View in: PubMed
    Score: 0.005
  97. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. N Engl J Med. 2020 12 10; 383(24):2320-2332.
    View in: PubMed
    Score: 0.005
  98. Respiratory syncytial virus vaccines: recent developments. Pediatr Infect Dis J. 2000 Aug; 19(8):805-8; discussion 809-10.
    View in: PubMed
    Score: 0.005
  99. Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study. Pediatr Infect Dis J. 2020 08; 39(8):706-712.
    View in: PubMed
    Score: 0.005
  100. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med. 2020 07 30; 383(5):426-439.
    View in: PubMed
    Score: 0.005
  101. Machine learning-based prediction of acute severity in infants hospitalized for bronchiolitis: a multicenter prospective study. Sci Rep. 2020 07 03; 10(1):10979.
    View in: PubMed
    Score: 0.005
  102. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020 07; 146(1).
    View in: PubMed
    Score: 0.005
  103. Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: A multicenter study. Pediatr Allergy Immunol. 2020 10; 31(7):755-766.
    View in: PubMed
    Score: 0.005
  104. Severe Coronavirus Bronchiolitis in the Pre-COVID-19 Era. Pediatrics. 2020 09; 146(3).
    View in: PubMed
    Score: 0.005
  105. Association of rhinovirus species with nasopharyngeal metabolome in bronchiolitis infants: A multicenter study. Allergy. 2020 09; 75(9):2379-2383.
    View in: PubMed
    Score: 0.004
  106. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans. J Infect Dis. 2020 02 03; 221(4):636-646.
    View in: PubMed
    Score: 0.004
  107. Non-gradient and genotype-dependent patterns of RSV gene expression. PLoS One. 2020; 15(1):e0227558.
    View in: PubMed
    Score: 0.004
  108. Increased Moraxella and Streptococcus species abundance after severe bronchiolitis is associated with recurrent wheezing. J Allergy Clin Immunol. 2020 02; 145(2):518-527.e8.
    View in: PubMed
    Score: 0.004
  109. Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants. J Infect Dis. 2019 10 22; 220(11):1802-1815.
    View in: PubMed
    Score: 0.004
  110. Rhinovirus Type in Severe Bronchiolitis and the Development of Asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):588-595.e4.
    View in: PubMed
    Score: 0.004
  111. Respiratory Virus Epidemiology Among US Infants With Severe Bronchiolitis: Analysis of 2 Multicenter, Multiyear Cohort Studies. Pediatr Infect Dis J. 2019 08; 38(8):e180-e183.
    View in: PubMed
    Score: 0.004
  112. Association of respiratory viruses with serum metabolome in infants with severe bronchiolitis. Pediatr Allergy Immunol. 2019 12; 30(8):848-851.
    View in: PubMed
    Score: 0.004
  113. Duplex real-time RT-PCR assay for detection and subgroup-specific identification of human respiratory syncytial virus. J Virol Methods. 2019 09; 271:113676.
    View in: PubMed
    Score: 0.004
  114. Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze. JAMA Pediatr. 2019 06 01; 173(6):544-552.
    View in: PubMed
    Score: 0.004
  115. Reply to Slogrove et al. Clin Infect Dis. 2019 05 30; 68(12):2158.
    View in: PubMed
    Score: 0.004
  116. Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women. Vaccine. 2019 06 06; 37(26):3464-3471.
    View in: PubMed
    Score: 0.004
  117. Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis. J Infect Dis. 2019 05 05; 219(11):1804-1808.
    View in: PubMed
    Score: 0.004
  118. Remote Laboratory Management: Respiratory Virus Diagnostics. J Vis Exp. 2019 04 06; (146).
    View in: PubMed
    Score: 0.004
  119. Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income Country. Clin Infect Dis. 2019 03 19; 68(7):1193-1203.
    View in: PubMed
    Score: 0.004
  120. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999 Mar; 103(3):619-26.
    View in: PubMed
    Score: 0.004
  121. Rhinovirus Species in Children With Severe Bronchiolitis: Multicenter Cohort Studies in the United States and Finland. Pediatr Infect Dis J. 2019 03; 38(3):e59-e62.
    View in: PubMed
    Score: 0.004
  122. Association of type 2 cytokines in severe rhinovirus bronchiolitis during infancy with risk of developing asthma: A multicenter prospective study. Allergy. 2019 07; 74(7):1374-1377.
    View in: PubMed
    Score: 0.004
  123. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J Allergy Clin Immunol. 2019 05; 143(5):1925-1928.e7.
    View in: PubMed
    Score: 0.004
  124. Severe bronchiolitis profiles and risk of recurrent wheeze by age 3?years. J Allergy Clin Immunol. 2019 04; 143(4):1371-1379.e7.
    View in: PubMed
    Score: 0.004
  125. Maternal immunization against viral disease. Vaccine. 1998 Aug-Sep; 16(14-15):1456-63.
    View in: PubMed
    Score: 0.004
  126. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis. 2018 10; 18(10):e295-e311.
    View in: PubMed
    Score: 0.004
  127. Nasopharyngeal CCL5 in infants with severe bronchiolitis and risk of recurrent wheezing: A multi-center prospective cohort study. Clin Exp Allergy. 2018 08; 48(8):1063-1067.
    View in: PubMed
    Score: 0.004
  128. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics. 1998 Jun; 101(6):1013-9.
    View in: PubMed
    Score: 0.004
  129. Respiratory Syncytial Virus and Rhinovirus Bronchiolitis Are Associated With Distinct Metabolic Pathways. J Infect Dis. 2018 03 13; 217(7):1160-1169.
    View in: PubMed
    Score: 0.004
  130. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. Pediatr Infect Dis J. 1998 Mar; 17(3):217-24.
    View in: PubMed
    Score: 0.004
  131. RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NF?B signaling. Pediatr Res. 2018 03; 83(3):606-614.
    View in: PubMed
    Score: 0.004
  132. Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field. Viral Immunol. 2018 03; 31(2):195-203.
    View in: PubMed
    Score: 0.004
  133. The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis. Microbiome. 2018 01 03; 6(1):2.
    View in: PubMed
    Score: 0.004
  134. Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis. J Infect Dis. 2017 12 27; 217(1):24-34.
    View in: PubMed
    Score: 0.004
  135. Influenza virus infections in infants. Pediatr Infect Dis J. 1997 Nov; 16(11):1065-8.
    View in: PubMed
    Score: 0.004
  136. Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study. Pediatr Infect Dis J. 2017 Nov; 36(11):1044-1051.
    View in: PubMed
    Score: 0.004
  137. Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology. Clin Infect Dis. 2017 Sep 15; 65(6):967-975.
    View in: PubMed
    Score: 0.004
  138. Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines. Clin Infect Dis. 2017 Sep 15; 65(6):1020-1025.
    View in: PubMed
    Score: 0.004
  139. Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy. J Infect Dis. 2017 09 15; 216(6):678-687.
    View in: PubMed
    Score: 0.004
  140. Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with Bronchiolitis. Pediatr Infect Dis J. 2017 08; 36(8):808-810.
    View in: PubMed
    Score: 0.004
  141. Characterizing the Cellular Immune Response to Parainfluenza Virus 3. J Infect Dis. 2017 07 15; 216(2):153-161.
    View in: PubMed
    Score: 0.004
  142. Marked variability observed in inpatient management of bronchiolitis in three Finnish hospitals. Acta Paediatr. 2017 Sep; 106(9):1512-1518.
    View in: PubMed
    Score: 0.004
  143. A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Vaccine. 2017 06 27; 35(30):3749-3759.
    View in: PubMed
    Score: 0.004
  144. The relationship between nasopharyngeal CCL5 and microbiota on disease severity among infants with bronchiolitis. Allergy. 2017 Nov; 72(11):1796-1800.
    View in: PubMed
    Score: 0.004
  145. Genomic Loads and Genotypes of Respiratory Syncytial Virus: Viral Factors during Lower Respiratory Tract Infection in Chilean Hospitalized Infants. Int J Mol Sci. 2017 Mar 21; 18(3).
    View in: PubMed
    Score: 0.004
  146. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis. PLoS One. 2017; 12(3):e0172953.
    View in: PubMed
    Score: 0.004
  147. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Nat Commun. 2016 12 21; 7:13916.
    View in: PubMed
    Score: 0.004
  148. Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis. J Allergy Clin Immunol. 2017 04; 139(4):1383-1386.e6.
    View in: PubMed
    Score: 0.004
  149. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J. 2016 11; 48(5):1329-1339.
    View in: PubMed
    Score: 0.003
  150. Anti-inflammatory effect of prophylactic macrolides on children with chronic lung disease: a protocol for a double-blinded randomised controlled trial. BMJ Open. 2016 09 16; 6(9):e012060.
    View in: PubMed
    Score: 0.003
  151. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats. J Virol. 2016 08 15; 90(16):7508-7518.
    View in: PubMed
    Score: 0.003
  152. Isolation of adenovirus type 7 from the urine of children with acute hemorrhagic cystitis. Pediatr Infect Dis J. 1996 Jul; 15(7):633-4.
    View in: PubMed
    Score: 0.003
  153. The Fecal Microbiota Profile and Bronchiolitis in Infants. Pediatrics. 2016 07; 138(1).
    View in: PubMed
    Score: 0.003
  154. A clustering approach to identify severe bronchiolitis profiles in children. Thorax. 2016 08; 71(8):712-8.
    View in: PubMed
    Score: 0.003
  155. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. J Infect Dis. 2016 10 01; 214(7):1010-9.
    View in: PubMed
    Score: 0.003
  156. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol. 2016 06; 137(6):1909-1913.e4.
    View in: PubMed
    Score: 0.003
  157. Post-bronchiolitis Use of Asthma Medication: A Prospective 1-year Follow-up Study. Pediatr Infect Dis J. 2016 Apr; 35(4):363-8.
    View in: PubMed
    Score: 0.003
  158. Children Hospitalized with Rhinovirus Bronchiolitis Have Asthma-Like?Characteristics. J Pediatr. 2016 05; 172:202-204.e1.
    View in: PubMed
    Score: 0.003
  159. Absence of Bordetella pertussis Among Infants Hospitalized for Bronchiolitis in Finland, 2008-2010. Pediatr Infect Dis J. 2016 Feb; 35(2):219-21.
    View in: PubMed
    Score: 0.003
  160. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. J Infect Dis. 2016 May 15; 213(10):1546-56.
    View in: PubMed
    Score: 0.003
  161. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J. 1996 Jan; 15(1):23-31.
    View in: PubMed
    Score: 0.003
  162. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process. Antimicrob Agents Chemother. 2015 Dec 14; 60(3):1264-73.
    View in: PubMed
    Score: 0.003
  163. Influenza virus pneumonia: pathogenesis, treatment, and prevention. Semin Respir Infect. 1995 Dec; 10(4):216-23.
    View in: PubMed
    Score: 0.003
  164. Detection of respiratory syncytial virus and rhinovirus in healthy infants. BMC Res Notes. 2015 Nov 25; 8:718.
    View in: PubMed
    Score: 0.003
  165. Prenatal Versus Postnatal Tobacco Smoke Exposure and Intensive Care Use in Children Hospitalized With Bronchiolitis. Acad Pediatr. 2016 07; 16(5):446-452.
    View in: PubMed
    Score: 0.003
  166. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2016 01; 60(1):6-13.
    View in: PubMed
    Score: 0.003
  167. Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High-income and Middle-income Countries. Pediatr Infect Dis J. 2015 Oct; 34(10):1086-92.
    View in: PubMed
    Score: 0.003
  168. Eligibility for palivizumab prophylaxis in a cohort of children with severe bronchiolitis. Pediatr Int. 2015 Oct; 57(5):1031-4.
    View in: PubMed
    Score: 0.003
  169. Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes. J Med Virol. 2016 Apr; 88(4):719-23.
    View in: PubMed
    Score: 0.003
  170. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine. 1995 Aug; 13(12):1095-101.
    View in: PubMed
    Score: 0.003
  171. Association Between Hyponatremia and Higher Bronchiolitis Severity Among Children in the ICU With Bronchiolitis. Hosp Pediatr. 2015 Jul; 5(7):385-9.
    View in: PubMed
    Score: 0.003
  172. Use of Cough and Cold Medications in Severe Bronchiolitis before and after a Health Advisory Warning against Their Use. J Pediatr. 2015 Jul; 167(1):196-8.e1-2.
    View in: PubMed
    Score: 0.003
  173. Variability of intensive care management for children with bronchiolitis. Hosp Pediatr. 2015 Apr; 5(4):175-84.
    View in: PubMed
    Score: 0.003
  174. Rhinovirus-induced bronchiolitis: Lack of association between virus genomic load and short-term outcomes. J Allergy Clin Immunol. 2015 Aug; 136(2):509-12.e11.
    View in: PubMed
    Score: 0.003
  175. Hospital course and discharge criteria for children hospitalized with bronchiolitis. J Hosp Med. 2015 Apr; 10(4):205-11.
    View in: PubMed
    Score: 0.003
  176. Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study. J Med Chem. 2015 Feb 26; 58(4):1630-43.
    View in: PubMed
    Score: 0.003
  177. Risk factors for requiring intensive care among children admitted to ward with bronchiolitis. Acad Pediatr. 2015 Jan-Feb; 15(1):77-81.
    View in: PubMed
    Score: 0.003
  178. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis. 2015 May 15; 211(10):1550-9.
    View in: PubMed
    Score: 0.003
  179. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis. 2015 May 15; 211(10):1529-40.
    View in: PubMed
    Score: 0.003
  180. Variability in inpatient management of children hospitalized with bronchiolitis. Acad Pediatr. 2015 Jan-Feb; 15(1):69-76.
    View in: PubMed
    Score: 0.003
  181. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein. EMBO Mol Med. 2014 Nov; 6(11):1436-54.
    View in: PubMed
    Score: 0.003
  182. Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis. Pediatr Infect Dis J. 2014 Aug; 33(8):809-13.
    View in: PubMed
    Score: 0.003
  183. Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis. Pediatr Infect Dis J. 2014 Aug; 33(8):829-34.
    View in: PubMed
    Score: 0.003
  184. Racial/ethnic differences in the presentation and management of severe bronchiolitis. J Hosp Med. 2014 Sep; 9(9):565-72.
    View in: PubMed
    Score: 0.003
  185. Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5992-7.
    View in: PubMed
    Score: 0.003
  186. Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in Texas. PLoS One. 2014; 9(3):e90786.
    View in: PubMed
    Score: 0.003
  187. Detection of NH1N1 influenza virus in nonrespiratory sites among children. Pediatr Infect Dis J. 2014 Jan; 33(1):95-6.
    View in: PubMed
    Score: 0.003
  188. Nasopharyngeal Proteobacteria are associated with viral etiology and acute wheezing in children with severe bronchiolitis. J Allergy Clin Immunol. 2014 Apr; 133(4):1220-2.
    View in: PubMed
    Score: 0.003
  189. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014 Feb; 58(3):319-27.
    View in: PubMed
    Score: 0.003
  190. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine. 1993 Nov; 11(14):1415-23.
    View in: PubMed
    Score: 0.003
  191. Apnea in children hospitalized with bronchiolitis. Pediatrics. 2013 Nov; 132(5):e1194-201.
    View in: PubMed
    Score: 0.003
  192. Community-acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013 Nov; 68(11):1000-6.
    View in: PubMed
    Score: 0.003
  193. Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised). BMC Res Notes. 2013 May 03; 6:177.
    View in: PubMed
    Score: 0.003
  194. [Universal immunisation against influenza in paediatrics, yes or no?]. An Pediatr (Barc). 2013 Oct; 79(4):261.e1-261.e11.
    View in: PubMed
    Score: 0.003
  195. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs. 2013 Mar-Apr; 5(2):263-9.
    View in: PubMed
    Score: 0.003
  196. Global gene expression profiling in infants with acute respiratory syncytial virus broncholitis demonstrates systemic activation of interferon signaling networks. Pediatr Infect Dis J. 2013 Feb; 32(2):e68-76.
    View in: PubMed
    Score: 0.003
  197. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. Vaccine. 1993; 11(7):718-24.
    View in: PubMed
    Score: 0.003
  198. Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. J Allergy Clin Immunol. 2012 Oct; 130(4):1007-8.e1.
    View in: PubMed
    Score: 0.003
  199. Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study. Pediatr Infect Dis J. 2012 Jul; 31(7):767-9.
    View in: PubMed
    Score: 0.003
  200. Description of an adenovirus type 8 outbreak in hospitalized neonates born prematurely. Pediatr Infect Dis J. 1992 Jun; 11(6):460-5.
    View in: PubMed
    Score: 0.003
  201. Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness. J Clin Microbiol. 2012 Feb; 50(2):506-8.
    View in: PubMed
    Score: 0.002
  202. Evaluation of an intravenous immunoglobulin preparation for the prevention of viral infection among hospitalized low birth weight infants. Pediatr Infect Dis J. 1990 Jul; 9(7):470-5.
    View in: PubMed
    Score: 0.002
  203. Incidence of catheter-associated gram-negative bacteremia in children with short bowel syndrome. J Clin Microbiol. 1989 Jun; 27(6):1317-9.
    View in: PubMed
    Score: 0.002
  204. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol. 2008 Sep; 82(17):8560-9.
    View in: PubMed
    Score: 0.002
  205. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr Infect Dis J. 2008 May; 27(5):444-52.
    View in: PubMed
    Score: 0.002
  206. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine. 2007 Nov 19; 25(47):8010-20.
    View in: PubMed
    Score: 0.002
  207. Rotavirus antigenemia in children is associated with viremia. PLoS Med. 2007 Apr; 4(4):e121.
    View in: PubMed
    Score: 0.002
  208. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine. 2007 May 16; 25(20):4038-45.
    View in: PubMed
    Score: 0.002
  209. Immunologic aspects of surface infections in the lung. J Pediatr. 1986 May; 108(5 Pt 2):817-23.
    View in: PubMed
    Score: 0.002
  210. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005 May; 50(4):322-30.
    View in: PubMed
    Score: 0.002
  211. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood. 2004 Oct 15; 104(8):2432-40.
    View in: PubMed
    Score: 0.002
  212. Safety of cold-adapted live influenza vaccine. Pediatr Infect Dis J. 2004 Jun; 23(6):593-4; author reply 594.
    View in: PubMed
    Score: 0.001
  213. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med. 2004 Jan; 158(1):65-73.
    View in: PubMed
    Score: 0.001
  214. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood. 2004 Feb 01; 103(3):1011-9.
    View in: PubMed
    Score: 0.001
  215. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol. 2003 Aug 15; 158(4):305-11.
    View in: PubMed
    Score: 0.001
  216. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine. 2003 Jul 28; 21(24):3465-7.
    View in: PubMed
    Score: 0.001
  217. Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses. Mol Ther. 2002 Mar; 5(3):233-41.
    View in: PubMed
    Score: 0.001
  218. Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis. Clin Infect Dis. 2001 May 15; 32(10):1423-9.
    View in: PubMed
    Score: 0.001
  219. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am J Respir Crit Care Med. 2001 Feb; 163(2):532-9.
    View in: PubMed
    Score: 0.001
  220. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis. 2000 Jun; 181(6):1891-6.
    View in: PubMed
    Score: 0.001
  221. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis. 2000 Mar; 181(3):1133-7.
    View in: PubMed
    Score: 0.001
  222. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr. 2000 Feb; 136(2):168-75.
    View in: PubMed
    Score: 0.001
  223. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000 Jan 26; 283(4):499-505.
    View in: PubMed
    Score: 0.001
  224. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci U S A. 1999 Oct 26; 96(22):12816-21.
    View in: PubMed
    Score: 0.001
  225. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis. 1998 Nov; 27(5):1194-200.
    View in: PubMed
    Score: 0.001
  226. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998 May 14; 338(20):1405-12.
    View in: PubMed
    Score: 0.001
  227. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J Infect Dis. 1998 May; 177(5):1394-7.
    View in: PubMed
    Score: 0.001
  228. Dual respiratory virus infections. Clin Infect Dis. 1997 Dec; 25(6):1421-9.
    View in: PubMed
    Score: 0.001
  229. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am J Med. 1997 Mar 17; 102(3A):61-70; discussion 75-6.
    View in: PubMed
    Score: 0.001
  230. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. J Med Virol. 1996 Oct; 50(2):105-11.
    View in: PubMed
    Score: 0.001
  231. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol. 1996 Jul; 34(7):1649-53.
    View in: PubMed
    Score: 0.001
  232. Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States. Clin Diagn Lab Immunol. 1996 Jul; 3(4):477-9.
    View in: PubMed
    Score: 0.001
  233. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group. J Infect Dis. 1996 Jun; 173(6):1313-9.
    View in: PubMed
    Score: 0.001
  234. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 1995 Sep; 16(3):393-9.
    View in: PubMed
    Score: 0.001
  235. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1994 Oct; 125(4):635-41.
    View in: PubMed
    Score: 0.001
  236. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol. 1991 Feb 01; 133(3):296-304.
    View in: PubMed
    Score: 0.001
  237. High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1990 Aug; 117(2 Pt 1):313-20.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.